FrancophonIA/ELRC3.0 huggingface dataset:
English: - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
Slovenian: - Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
English: Crystalluria related to the use of ciprofloxacin has been reported.
Slovenian: Poročali so o kristaluriji, povezani z uporabo ciprofloksacina.
English: Ciprofloxacin Hikma is used for the treatment of severe and/or life-threatening infections caused by ciprofloxacin-sensitive microorganisms.
Slovenian: Zdravilo Ciprofloxacin Hikma se uporablja za zdravljenje resnih in/ali smrtno nevarnih okužb, ki jih povzročajo patogeni mikroorganizmi, dovzetni za ciprofloksacin.
English: Keep the vial in the outer carton until time of use in order to protect from light.
Slovenian: Vialo do uporabe shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Twice daily intravenous administration of 15 mg/kg bodyweight, or 10 mg/kg bodyweight three times daily (maximum of 1200 mg per day), then twice daily oral administration.
Slovenian: Intravensko odmerjanje 15 mg/kg telesne mase dvakrat na dan ali 10 mg/kg telesne mase trikrat na dan (največ 1200 mg na dan), nato pa peroralno odmerjanje dvakrat na dan.
English: WHAT CIPROFLOXACIN HIKMA IS AND WHAT IT IS USED FOR
Slovenian: KAJ JE ZDRAVILO CIPROFLOXACIN HIKMA IN ZA KAJ GA UPORABLJAMO
English: Rare: pseudomembranous colitis, moniliasis (oral).
Slovenian: Redki: psevdomembranski kolitis, kandidoza (oralna).
English: This condition is life-threatening and may have a fatal outcome.
Slovenian: Ta bolezen je smrtno nevarna;
English: Rare: myalgia (muscular pain), joint disorder (swollen joints).
Slovenian: Redki: mialgija (bolečine v mišicah), bolezni sklepov (otečeni sklepi).
English: The body of published literature and resistance data presented by the applicant provided adequate justification, both from an efficacy and safety (more likely to prevent bacterial resistance and no increase in adverse reactions) viewpoint, for the dosing regimen of 200-400 mg ciprofloxacin twice daily for the treatment of complicated UTI.
Slovenian: Objavljena literatura in podatki o odpornosti, ki jih je predstavil vlagatelj, primerno upravičujejo shemo odmerjanja z 200 do 400 mg ciprofloksacina dvakrat dnevno pri zdravljenju zapletenih okužb sečil tako z vidika učinkovitosti kot tudi z vidika varnosti (povečana verjetnost preprečitve pojava odpornosti bakterij brez ojačitve neželenih učinkov).
English: Rare (≥1/10,000 to <1/1,000)
Slovenian: Redki (≥ 1/10.000 do < 1/1000)
English: Non-species related breakpoints are ≤ 0,5 µg/ml for susceptible, and > 1 µg/ml for resistant organisms.
Slovenian: Mejne vrednosti, neodvisne od vrste, so ≤ 0,5 µg/ml za dovzetne in > 1 µg/ml za rezistentne organizme.
English: Very rare: pulmonary oedema in case of shock (anaphylactic; life-threatening), itching rash, serum sickness-like symptoms.
Slovenian: Zelo redki: pljučni edem v primeru šoka (anafilaktični; smrtno nevaren), srbeč izpuščaj, simptomi, podobni serumski bolezni.
English: ESBL: Extended Spectrum Beta-lactamases MRSA: Methicillin-resistant Staphylococcus aureus
Slovenian: MRSA: Staphylococcus aureus, rezistenten na meticilin (Methicillin-resistant Staphylococcus aureus).
English: • Keep the vial in the outer carton until time of use in order to protect from light.
Slovenian: • Vialo do uporabe shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Common in more than 1 in 100 patients, but less than 1 in 10 patients
Slovenian: Pogosti pri več kot 1 bolniku od 100, vendar manj kot 1 bolniku od 10
English: Ciprofloxacin Hikma is indicated for the treatment of serious and/or life-threatening infections caused by ciprofloxacin-susceptible pathogens.
Slovenian: Zdravilo Ciprofloxacin Hikma je indicirano za zdravljenje resnih in/ali smrtno nevarnih okužb, ki jih povzročajo patogeni mikroorganizmi, dovzetni za ciprofloksacin.
English: The reconstituted solution should be inspected visually for particulate matter and discoloration prior to administration.
Slovenian: Rekonstituirano raztopino je treba pred uporabo vizualno pregledati ter preveriti, ali so v njej delci in ali je spremenila barvo.
English: If creatinine clearance is ≤ 30 ml/minute/1.73 m2 or the serum creatinine concentration is ≥ 175 µmol/l, the maximum daily intravenous dose is 400 mg.
Slovenian: Če je kreatininski očistek ≤ 30 ml/min/1,73 m2 ali če je koncentracija kreatinina v serumu
English: UK
Slovenian: Nemčija
English: Uncommon (≥1/1 000 to <1/100)
Slovenian: Občasni (≥ 1/1000 do < 1/100)
English: Common: perverted sensation of taste (usually reversible upon discontinuation of treatment), dizziness, headache, insomnia, agitation, confusion.
Slovenian: Pogosti: motnje okušanja (ponavadi reverzibilne po prekinitvi zdravljenja), omotica, glavobol, insomnija, agitacija, konfuznost.
English: • patients with a history of tendon disorder related to fluoroquinolone administration
Slovenian: • bolnikih z okvaro kit, povezano z uporabo fluorokinolonov v anamnezi;
English: Rare: oedema (peripheral, angio, facial), allergic reaction, drug fever, anaphylactoid (anaphylactic) reaction.
Slovenian: Redki: edem (periferni edem, angioedem, edem obraza), alergijske reakcije, zvišana telesna temperatura zaradi uporabe zdravila, anafilaktoidne (anafilaktične) reakcije.
English: These side effects occur predominantly in patients at risk for certain heart disorders.
Slovenian: Pri teh bolnikih se namreč poveča nevarnost pojava stranskih učinkov, povezanih z vplivom zdravila na osrednje živčevje.
English: Like with other gyrase inhibitors, ciprofloxacin may induce joint damage during the growth phase of juvenile animals.
Slovenian: Ciprofloksacin lahko, tako kot drugi zaviralci giraze, pri neodraslih živalih povzroči poškodbe sklepov v fazi rasti.
English: Rare in more than 1 in 10,000 patients, but less than 1 in 1,000 patients
Slovenian: Redki pri več kot 1 bolniku od 10.000, vendar manj kot 1 bolniku od 1.000
English: You should consult your doctor if one of the precautions and warnings mentioned below are or were applicable to you in the past.
Slovenian: Bodite posebno pozorni pri uporabi zdravila Ciprofloxacin Hikma Posvetujte se z zdravnikom, če katero koli spodaj navedeno varnostno opozorilo velja za vas ali je v preteklosti veljalo za vas:
English: Estrada do Rio da Mó, 8, 8A e 8B - Fervença 2705-906 Terrugem SNT Portugal
Slovenian: Estrada do Rio da Mó, 8, 8A e 8B - Fervença 2705-906 Terrugem SNT Portugalska
English: He/she may find it necessary to adjust your dose due to a reduced kidney function.
Slovenian: Morda vam bo glede na zmanjšano delovanje ledvic prilagodil odmerek.
English: The transaminase or alkaline phosphatase concentrations may temporarily increase or cholestatic icterus might occur, especially in patients with previous liver damage.
Slovenian: Pri bolnikih z obstoječo jetrno okvaro se lahko začasno zvišajo vrednosti transaminaz in alkalne fosfataze ali pa se lahko pojavi holestatska zlatenica.
English: Marketing Authorisation Holder Applicant
Slovenian: IMETNIK DOVOLJENJA ZA PROMET
English: The following infections may be treated intravenously (via the blood) with Ciprofloxacin Hikma:
Slovenian: Z zdravilom Ciprofloxacin Hikma se lahko intravensko (po krvi) zdravijo naslednje okužbe:
English: Estrada do Rio da Mó n.º 8, 8A e 8B - Fervença 2705-906 Terrugem SNT Portugal
Slovenian: Estrada do Rio da Mó n.o 8, 8A e 8B - Fervença 2705-906 Terrugem SNT Portugalska
English: Ciprofloxacin inhibits this enzyme.
Slovenian: Ciprofloksacin ta encim zavira.
English: Premedicants
Slovenian: Premedikacija
English: Do not use Ciprofloxacin Hikma after the expiry date which is stated on the packaging after “Exp”.
Slovenian: Zdravila Ciprofloxacin Hikma ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini poleg oznake Uporabno do. Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: • complicated urinary tract infections
Slovenian: • zapletene okužbe sečil;
English: dosage the elimination half-life is between 3 - 4.6 hours.
Slovenian: Po enkratnih in večkratnih intravenskih odmerkih je razpolovni čas med 3 in 4,6 ur.
English: The diluted solution should be inspected visually for particulate matter and discoloration prior to administration.
Slovenian: Razredčeno raztopino je treba pred uporabo vizualno pregledati in preveriti, ali so v njej delci in ali je spremenila barvo.
English: Ciprofloxacin may cause an exacerbation of Myastenia gravis symptoms.
Slovenian: Ciprofloksacin lahko povzroči eksacerbacijo simptomov miastenije gravis.
English: After oral administration ciprofloxacin is excreted unchanged for approx. 70% and after i.v.
Slovenian: Po peroralni uporabi se približno 70 % ciprofloksacina izloči nespremenjenega, po intravenski pa približno 77 %.
English: Uncommon in more than 1 in 1,000 patients, but less than 1 in 100 patients
Slovenian: Občasni pri več kot 1 bolniku od 1000, vendar manj kot 1 bolniku od 100
English: Do NOT use Ciprofloxacin Hikma:
Slovenian: NE uporabljate zdravila Ciprofloxacin Hikma:
English: Enterobacter spp.
Slovenian: Enterobacter aerogenes Enterobacter spp.
English: Uncommon: pruritis, papillo-macular rash, urticaria.
Slovenian: Občasni: pruritus, papilomakularni izpuščaj, urtikarija.
English: The active substance is ciprofloxacin lactate.
Slovenian: Zdravilna učinkovina je ciprofloksacinlaktat.
English: • Concurrent administration of ciprofloxacin and tizanidine
Slovenian: • sočasni uporabi ciprofloksacina in tizanidina.
English: Local reactions have been reported after intravenous administration of ciprofloxacin.
Slovenian: Po intravenski uporabi ciprofloksacina so poročali o lokalnih reakcijah.
English: Acinetobacter spp.
Slovenian: Acinetobacter baumannii Enterobacter spp.
English: It should only be administered with great caution to persons with renal insufficiency, or severe dehydration.
Slovenian: Osebam z ledvično insuficienco ali hudo dehidracijo je treba ciprofloksacin dajati previdno.
English: Uncommon: - fungal infection (mobilises) - increase in eosinophilic cells (eosinophilia), reduction in white blood cells (leucopenia) which makes infections more likely - inflammation of a vein related to a blood clot (thrombophlebitis); the vein is often sensed as a tender hard strand covered with red skin - vomiting, digestive disorders, gassiness (flatulence), loss of appetite, abdominal pain - itching (pruritus), spot-shaped rash (maculopapular rash), hives (urticaria) - joint pain (arthralgia) - general sensation of weakness, fatigue (asthenia), irritation or pain at the injection site - increase of the creatinine or urea level in the blood, abnormal liver function test results, bile pigment in the blood (bilirubinaemia) and increased blood level of a certain enzyme (alkaline phosphatase) - pulmonary embolism, laboured breathing (dyspnoea), pulmonary oedema, nosebleed (epistaxis),
Slovenian: Občasni: - glivične okužbe (kandidoza); - povečanje števila eozinofilcev (eozinofilija), zmanjšanje števila levkocitov (levkopenija), zaradi katere se poveča verjetnost okužb; - vnetje ven, povezano s krvnim strdkom (tromboflebitis); veno pogosto lahko čutite kot bolečo trdo vrvico, prekrito z rdečo kožo; - bruhanje, prebavne težave, vetrovi (flatulenca), izguba apetita, bolečine v trebuhu; - srbenje (pruritus), pikčasti izpuščaj (makulopapulozni izpuščaj), koprivnica (urtikarija); - bolečine v sklepih (artralgija); - splošni občutek šibkosti, utrujenost (astenija), draženje ali bolečina na mestu injiciranja; - zvišanje ravni kreatinina ali sečnine v krvi, nenormalni rezultati jetrnih preiskav, žolčni pigment v krvi (bilirubinemija) in zvišana raven določenega encima (alkalne fosfataze) v krvi; - pljučna embolija, oteženo dihanje (dispneja), pljučni edem, krvavitev iz nosu (epistaksa),
English: Ciprofloxacin Hikma 200 mg/100 ml, solution for infusion [To be completed nationally]
Slovenian: Ciprofloxacin Hikma 200 mg/100 ml, raztopina za infundiranje [[Izpolni država članica.]
English: HOW TO USE CIPROFLOXACIN HIKMA
Slovenian: KAKO UPORABLJATI ZDRAVILO CIPROFLOXACIN HIKMA
English: Ciprofloxacin lactate equivalent to 2 mg ciprofloxacin.
Slovenian: 1 ml raztopine za infundiranje vsebuje: ciprofloksacinlaktat, ki ustreza 2 mg ciprofloksacina.
English: Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin potentially leading to increased plasma levels of methotrexate.
Slovenian: Pri sočasni uporabi ciprofloksacina in metotreksata lahko pride do zaviranja tubulnega transporta metotreksata, zaradi česar se njegova koncentracija v plazmi zveča.
English: Musculoskeletal system:
Slovenian: Mišice in skelet:
English: - inflammation of blood vessels (vasculitis) characterised by: small spots caused by bleeding in the skin (petechiae), bloody blisters (haemorrhagic bullae), skin nodes (papules), formation of eschar (dead tissue that sheds (sloughs-off) from healthy skin) - fungal infection in the gastrointestinal system (gastrointestinal moniliasis), pancreas inflammation (pancreatitis) - liver inflammation (hepatitis), destruction of liver tissue (liver cell necrosis, very rarely resulting in lifethreatening liver failure) - rash with red (moist) irregular spots (erythema (exsudativum) multiforme), tender bluish red bumps in the skin (erythema nodosum), severe condition with (high) fever, red spots on the skin, joint pains and/or eye infection (Stevens-Johnson syndrome), severe condition with fever and blisters on the skin/peeling of the skin (Lyell syndrome), small purplish red spot (petechia) - inflammation of the tendons (tendinitis, in particular of the Achilles tendon), partial or total tendon ruptures (in particular of the Achilles tendon), exacerbation of the symptoms of myasthenia gravis (a particular type of muscle weakness), muscular pains, inflammation of tendon sheaths (tenosynovitis) - increased blood level of amylase (enzyme that breaks down starch) and lipase (enzyme that breaks down fats).
Slovenian: Ti neželeni učinki se pojavljajo večinoma pri bolnikih s tveganjem za nekatere bolezni srca; - vnetje krvnih žil (vaskulitis), za katerega so značilni naslednji znaki: majhne pike, ki jih povzročajo krvavitve v koži (petehije), krvavi mehurji (hemoragične bule), kožne bunčice (papule), tvorba eshar (mrtvega tkiva, ki odpada (se lušči) z zdrave kože); - glivične okužbe prebavil (gastrointestinalna kandidoza), vnetje trebušne slinavke (pankreatitis); - vnetje jeter (hepatitis), razkroj jetrnega tkiva (nekroza jetrnih celic, zelo redko lahko povzroči smrtno nevarno jetrno odpoved); - izpuščaj z rdečimi (vlažnimi) nepravilnimi pikami (multiformni (eksudativni) eritem), boleče modrikasto-rdeče izbokline na koži (nodozni eritem), huda bolezen z (zelo) zvišano telesno temperaturo, rdečimi pikami na koži, bolečino v sklepih in/ali okužbo oči (Stevens-Johnsonov sindrom), huda bolezen z zvišano telesno temperaturo in mehurji na koži/luščenjem kože (Lyellov sindrom), majhne vijoličasto-rdeče pike (petehija); - vnetje kit (tendinitis, zlasti ahilove kite), delno ali celotno pretrganje kit (zlasti ahilove kite), poslabšanje simptomov miastenije gravis (posebne vrste mišične šibkosti), bolečine v mišicah, vnetje ovojnic kit (tendosinovitis); - zvišana raven amilaze (encima, ki razgrajuje škrob) in lipaze (encima, ki razgrajuje maščobe) v krvi; - šibkost (astenija), prehodno poslabšanje delovanja ledvic do prehodne ledvične odpovedi, preobčutljivost za svetlobo.
English: • In patients with a history of tendon disorder related to fluoroquinolone administration
Slovenian: • če imate okvaro kit, povezano z uporabo fluorokinolona v preteklosti;
English: Uncommon: pulmonary embolism, dyspnoea, pulmonary oedema, epistaxis, haemoptysis and hiccough.
Slovenian: Občasni: pljučna embolija, dispneja, pljučni edem, epistaksa, hemoptiza in kolcanje.
English: Solution for infusion
Slovenian: Infusion
English: Staphylococcus haemolyticus Gram-negative aerobes
Slovenian: Enterococcus faecium Staphylococcus epidermidis Staphylococcus haemolyticus Gramnegativni aerobi Multirezistentna E. coli Providencia spp.
English: Ciprofloxacin Hikma 200mg/100ml Soluzione per Infusione Endovenosa
Slovenian: 200 mg/100 ml Soluzione per Infusione Endovenosa
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Ciprofloxacin Hikma 200 mg/100 ml, solution for infusion [To be completed nationally] ciprofloxacin Intravenous use METHOD OF ADMINISTRATION Read the package leaflet before use.
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Ciprofloxacin Hikma 200 mg/100 ml, raztopina za infundiranje [[Izpolni država članica.]
English: BATCH NUMBER
Slovenian: Kartonska škatla
English: Take special care with Ciprofloxacin Hikma
Slovenian: Ciprofloxacin Hikma
English: FURTHER INFORMATION What Ciprofloxacin Hikma contains
Slovenian: Kaj vsebuje zdravilo Ciprofloxacin Hikma
English: HOW TO STORE CIPROFLOXACIN HIKMA Keep out of the reach and sight of children.
Slovenian: SHRANJEVANJE ZDRAVILA CIPROFLOXACIN HIKMA Zdravilo shranjujte nedosegljivo otrokom!
English: Uncommon: eosinophilia, leukopenia.
Slovenian: Bolezni krvi in limfatičnega sistema: Občasni: eozinofilija, levkopenija.
English: Very rare: - reduction in red blood cells due to extensive destruction of these cells (haemolytic anaemia), severe reduction in blood cells (pancytopenia), severe reduction in white blood cells characterised by sudden high fever, very sore throat and mouth ulcers (agranulocytosis) - a life-threatening condition characterised by a sharp drop in the blood pressure, paleness, restlessness, weak/quick pulse, clammy skin, dizziness as a result of severe allergy to this medicine (anaphylactic shock), itching rash, fever, joint swellings, muscle pains, rash (symptoms similar to those occurring in a disease called serum sickness) - disturbed control of own behaviour and actions (psychotic reactions which may progress to selfendangering behaviour) - smell disorder (parosmia), loss of smell (anosmia, the smell usually returns after termination of treatment), convulsions (grand mal convulsion), abnormal (unstable) gait, increased pressure in the head (intracranial hypertension), lack of coordination (ataxia), increased sensitivity to stimulation (hyperaesthesia), stiffness (hypertonia) - irregular heart beat (ventricular arrhythmia), abnormal electrocardiogram heart tracing, lifethreatening increased heart rate (torsade de pointes).
Slovenian: (anafilaktični šok), srbeči izpuščaj, zvišana telesna temperatura, otekanje sklepov, bolečine v mišicah, izpuščaj (simptomi, podobni tistim, ki se pojavijo pri bolezni, imenovani serumska bolezen); - moten nadzor nad lastnim vedenjem in delovanjem (psihotične reakcije, ki lahko napredujejo do samomorilskega vedenja); - motnje voha (parozmija), izguba voha (anozmija, voh se po navadi povrne po končanem zdravljenju), epileptični napadi (generalizirani), nenormalna (nestabilna) hoja, zvišan tlak v glavi (intrakranialna hipertenzija), pomanjkanje koordinacije (ataksija), povečana občutljivost za dražljaje (hiperestezija), otrdelost (hipertonija); - nereden srčni utrip (ventrikularna aritmija), nenormalni elektrokardiogram, smrtno nevaren pospešen utrip (aritmija "torsade de pointes").
English: Ciprofloxacin Hikma 200 mg/100 ml, solution for infusion [To be completed nationally] ciprofloxacin
Slovenian: Ciprofloxacin Hikma 200 mg/100 ml, raztopina za infundiranje [Izpolni država članica.]
English: Lactation:
Slovenian: Sečila:
English: Acute lower respiratory tract infections caused by Pseudomonas aeruginosa in children and adolescents years)
Slovenian: Akutne okužbe spodnjih dihal, ki jih povzroča bakterija Pseudomonas aeruginosa pri otrocih in mladostnikih (od 5 do 17 let) s cistično fibrozo:
English: Mexiletine
Slovenian: Italija
English: - perspiration
Slovenian: Odmerjanje
English: Ciprofloxacin Hikma 200mg/100ml Oplossing voor Intraveneuze Infusie
Slovenian: 200 mg/100 ml Oplossing voor Intraveneuze Infusie
English: Ciprofloxacin Hikma 200mg/100ml Lösung zur intravenösen Anwendung
Slovenian: 200 mg/100 ml Lösung zur intravenösen Anwendung
English: ANNEX I LIST OF THE INVENTED NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Slovenian: PRILOGA I SEZNAM IZMIŠLJENIH IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVIL, POT UPORABE IN IMETNIKI DOVOLJENJ ZA PROMET V DRŽAVAH ČLANICAH
English: 0.40% Syrup
Slovenian: 0,40 % sirup
English: CLOBUTINOL CONTAINING MEDICINAL PRODUCTS WITH MARKETING AUTHORISATION IN THE EUROPEAN UNION Member State
Slovenian: ZDRAVILA, KI VSEBUJEJO KLOBUTINOL IN IMAJO DOVOLJENJE ZA PROMET V EVROPSKI UNIJI Država članica
English: Orion Corporation, ORION PHARMA,Tengströminkatu 8, P.O.Box 425, 20101 Turku, Finland
Slovenian: Orion Corporation, ORION PHARMA,Tengströminkatu 8, P.O.Box 425, 20101 Turku, Finska
English: D-51381 Leverkusen Germany
Slovenian: D-51381 Leverkusen Nemčija
English: Boehringer Ingelheim Finland Ky, Tammasaarenkatu 5, 00180 Helsinki, Finland
Slovenian: Boehringer Ingelheim Finland Ky, Tammasaarenkatu 5, 00180 Helsinki, Finska
English: 40 mg Tablets
Slovenian: 40 mg tablete
English: Intramuscular or intravenous use
Slovenian: raztopina za injiciranje intramuskularna ali intravenska uporaba
English: Czech Republic Boehringer Ingelheim GmbH Binger Strasse 173
Slovenian: Češka republika Boehringer Ingelheim GmbH Binger Strasse 173
English: Belgium SCS Boehringer Ingelheim Comm.V., Avenue Ariane 16
Slovenian: SCS Boehringer Ingelheim Comm.V., Avenue Ariane 16
English: 6 g/ 100 g Oral drops, solution kohlpharma GmbH Im Holzhau 8 d-66663 Merzig Germany
Slovenian: 6 g/ 100 g peroralne kapljice, raztopina kohlpharma GmbH Im Holzhau 8 d-66663 Merzig Nemčija
English: 40 mg Coated tablets
Slovenian: 40 mg obložene tablete
English: Silomat Compositum (Clobutinol HCl +
Slovenian: Compositum (Clobutinol HCl + Orciprenaline Sulfate)
English: ClobutinolMIP Tropfen 80 mg/ml
Slovenian: Clobutinol-MIP Tropfen 80 mg/ml
English: Hustenstillerratiopharm Clobutinol ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Slovenian: Hustenstillerratiopharm Clobutinol ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Nemčija
English: Rofatuss forte 80 mg Capsule, hard
Slovenian: Rofatuss forte 80 mg kapsula, trda
English: 80 mg Capsule, hard ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Slovenian: 80 mg kapsula, trda ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Nemčija
English: 4 mg/1 ml Oral solution
Slovenian: 4 mg/1 ml peroralna raztopina
English: Silomat Dragees gegen Reizhusten
Slovenian: Silomat Dragees gegen
English: 60mg Oral solution
Slovenian: 60 mg peroralna raztopina
English: Rofatuss N 40 mg Capsule, hard
Slovenian: Rofatuss N 40 mg kapsula, trda
English: 80 mg Capsule, hard
Slovenian: 80 mg kapsule, trde
English: 60 mg/ml Oral drops, solution
Slovenian: 60 mg/ml peroralna raztopina, kapljice
English: ClobutinolMIP Kapsel 40 mg
Slovenian: Clobutinol-MIP Kapsel 40 mg
English: Silomat Tropfen gegen Reithusten
Slovenian: Silomat Tropfen gegen
English: 40 mg Capsule, hard
Slovenian: 40 mg kapsula, trda
English: Reizhusten ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Slovenian: Silomat Saft gegen ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Nemčija
English: Tussed Hustenstiller Tropfen
Slovenian: Tussed Hustenstiller Tropfen raztopina
English: Reizhusten
Slovenian: Pot uporabe
English: The absolute bioavailability is about 64%.
Slovenian: Absolutna biološka uporabnost je približno 64 %.
English: Tell your doctor if you think this applies to you.
Slovenian: Povejte zdravniku, če mislite, da to velja za vas.
English: How do I know that the injection is complete?
Slovenian: Kako vem, da je postopek injiciranja zaključen?
English: This will make sure you get your full dose.
Slovenian: Tako boste zagotovili, da ste prejeli celotni odmerek.
English: There may be new information.
Slovenian: Morda bodo v njej na voljo nove informacije.
English: The individual daily dose is to be maintained throughout the stimulation period.
Slovenian: Posamezen dnevni odmerek je treba vzdrževati ves čas spodbujevalnega obdobja.